Avenue Therapeutics Inc. (ATXI)
NASDAQ: ATXI
· Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM
Avenue Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.86M | -1.56M | -3.09M | -2.7M | -4.34M | 640K | 513K | -4.02M | -7.6M | 524K | -662K | -604K | -2.86M | -913K | -871K | -949K | -998K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 185K | 522K | 331K | 192K | 191K | 307K | 561K | 27K | 11K | 12K | 25K | 43K | 569K | 143K | 69K | 116K | 114K |
Other Working Capital | n/a | -194K | -129K | 47K | -49K | 190K | -188K | -1.88M | 2.93M | -40K | 95K | -328K | 67K | -617.59K | 451K | 129K | 45K |
Other Non-Cash Items | n/a | 467K | -4K | 94K | 491K | -2.36M | -1.57M | 2.15M | 2.18M | -5.05M | 37K | 433K | 191K | 498K | -230K | 36K | 531K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -373K | -129K | 162K | 340K | -911K | -391K | -2.83M | 3.84M | 345K | 83K | -382K | 362K | -433K | 266K | 129K | -423K |
Operating Cash Flow | -1.19M | -764K | -2.89M | -2.25M | -3.12M | -2.32M | -889K | -4.67M | -1.57M | -4.17M | -554K | -943K | -1.93M | -1.2M | -536K | -704K | -1.31M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 3M | -1M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -3M | -1K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 3M | -1M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.04M | 5.77M | 567K | 3.68M | 4.53M | 72K | -71K | n/a | n/a | 10.66M | -119K | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 2.09M | 761K | 567K | 3.98M | 4.53M | 3.95M | 479K | n/a | 3.1M | 10.66M | -119K | n/a | n/a | 4.38K | n/a | n/a | n/a |
Net Cash Flow | 908K | -3K | -2.32M | 1.73M | 1.41M | 1.62M | -1.41M | -6.67M | 1.53M | 6.49M | -673K | -943K | -1.93M | 3.18M | -536K | -704K | -1.31M |
Free Cash Flow | -1.19M | -764K | -2.89M | -2.25M | -3.12M | 676K | -1.89M | -6.67M | -1.57M | -4.17M | -554K | -943K | -1.93M | -1.2M | -536K | -704K | -1.31M |